Skip to main content
PMC home page
British Journal of Experimental Pathology logoLink to British Journal of Experimental Pathology
. 1975 Oct;56(5):389–395.

Effects on serum complement of normal and pre-eclamptic pregnancy and of oral contraceptives.

R S Tedder, M Nelson, V Eisen
PMCID: PMC2072786  PMID: 1212421

Abstract

The complement system was studied in normal gestation and puerperium, in pre-eclampsia and in women taking oral contraceptives. In 12 normal pregnancies, CH50 titres, C4, C3, C6 and C7 were increased throughout pregnancy; the serum concentration of C1 inhibitor was decreased in the last 2 quarters but greatly raised after delivery. Oral oestrogen-progestogen contraceptives also raised C3 but in contrast to pregnancy lowered CH50, C6 and C7. The different effects of pregnancy and of oral contraceptives may be due to materno-foetal immune reactions. In 9 patients with pre-eclamplsia, complement levels showed a wider scatter and a significantly higher C3 level than in normal pregnancy. Conversion of C3 to C3i was found in 2 of these patients.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amir J., Pensky J., Ratnoff O. D. Plasma inhibition of activated plasma thromboplastin antecedent (factor XIa) in pregnancy. J Lab Clin Med. 1972 Jan;79(1):106–112. [PubMed] [Google Scholar]
  2. Charlesworth J. A., Williams D. G., Sherington E., Lachmann P. J., Peters D. K. Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia. J Clin Invest. 1974 Jun;53(6):1578–1587. doi: 10.1172/JCI107708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Donaldson V. H. Serum inhibitor of C'1-esterase in health and disease. J Lab Clin Med. 1966 Sep;68(3):369–382. [PubMed] [Google Scholar]
  4. Eisen V., Loveday C. Activation of arginine and tyrosine esterase in serum from patients with hereditary angio-oedema. Br J Pharmacol. 1972 Sep;46(1):157–166. doi: 10.1111/j.1476-5381.1972.tb06858.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. HOLLANDER C. S., GARCIA A. M., STURGIS S. H., SELENKOW H. A. EFFECT OF AN OVULATORY SUPPRESSANT ON THE SERUM PROTEIN-BOUND IODINE AND THE RED-CELL UPTAKE OF RADIOACTIVE TRI-IODOTHYRONINE. N Engl J Med. 1963 Sep 5;269:501–504. doi: 10.1056/NEJM196309052691004. [DOI] [PubMed] [Google Scholar]
  6. Howie P. W., Mallinson A. C., Prentice C. R., Horne C. H., McNicol G. P. Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity. Lancet. 1970 Dec 26;2(7687):1329–1332. doi: 10.1016/s0140-6736(70)92358-5. [DOI] [PubMed] [Google Scholar]
  7. Howie P. W., Prentice C. R., McNicol G. P. Coagulation, fibrinolysis and platelet function in pre-eclampsia, essential hypertension and placental insufficiency. J Obstet Gynaecol Br Commonw. 1971 Nov;78(11):992–1003. doi: 10.1111/j.1471-0528.1971.tb00216.x. [DOI] [PubMed] [Google Scholar]
  8. Kitzmiller J. L., Benirschke K. Immunofluorescent study of placental bed vessels in pre-eclampsia of pregnancy. Am J Obstet Gynecol. 1973 Jan 15;115(2):248–251. doi: 10.1016/0002-9378(73)90293-7. [DOI] [PubMed] [Google Scholar]
  9. LAURELL C. B. ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS. Anal Biochem. 1965 Feb;10:358–361. doi: 10.1016/0003-2697(65)90278-2. [DOI] [PubMed] [Google Scholar]
  10. LAYNE D. S., MEYER C. J., VAISHWANAR P. S., PINCUS G. The secretion and metabolism of cortisol and aldosterone in normal and in steroid-treated women. J Clin Endocrinol Metab. 1962 Feb;22:107–118. doi: 10.1210/jcem-22-2-107. [DOI] [PubMed] [Google Scholar]
  11. LEVY L. R., LEPOW I. H. Assay and properties of serum inhibitor of C'l-esterase. Proc Soc Exp Biol Med. 1959 Aug-Sep;101:608–611. doi: 10.3181/00379727-101-25034. [DOI] [PubMed] [Google Scholar]
  12. Langford H. G., Douglas B. H., Arhelger R. B. A model of preeclampsia. I. Blood pressure changes produced by anti-placenta serum. Johns Hopkins Med J. 1967 Apr;120(4):213–219. [PubMed] [Google Scholar]
  13. Laurell C. B., Kullander S., Thorell J. Effect of administration of a combined estrogen-progestin contraceptive on the level of individual plasma proteins. Scand J Clin Lab Invest. 1968;21(4):337–343. doi: 10.3109/00365516809077003. [DOI] [PubMed] [Google Scholar]
  14. Levanon Y., Rossetini S. M. Presence of circulating placental antigens and antibodies in toxemic and normal pregnancy patients. Z Immunitatsforsch Allerg Klin Immunol. 1968 Aug;136(2):178–186. [PubMed] [Google Scholar]
  15. MAGARA M. A study on the intrinsic factors of the toxaemia of pregnancy. Pathol Microbiol (Basel) 1961;24:670–680. doi: 10.1159/000161180. [DOI] [PubMed] [Google Scholar]
  16. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  17. McCormick J. N., Faulk W. P., Fox H., Fudenberg H. H. Immunohistological and elution studies of the human placenta. J Exp Med. 1971 Jan 1;133(1):1–18. doi: 10.1084/jem.133.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nicol P. A., Lachmann P. J. The alternate pathway of complement activation. The role of C3 and its inactivator (KAF). Immunology. 1973 Feb;24(2):259–275. [PMC free article] [PubMed] [Google Scholar]
  19. OSLER A. G., STRAUSS J. H., MAYER M. M. Diagnostic complement fixation. I. A method. Am J Syph Gonorrhea Vener Dis. 1952 Mar;36(2):140–153. [PubMed] [Google Scholar]
  20. Petrucco O. M., Thomson N. M., Lawrence J. R., Weldon M. W. Immunofluorescent studies in renal biopsies in pre-eclampsia. Br Med J. 1974 Mar 16;1(5906):473–476. doi: 10.1136/bmj.1.5906.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. ROBBINS J., RALL J. E. Proteins associated with the thyroid hormones. Physiol Rev. 1960 Jul;40:415–489. doi: 10.1152/physrev.1960.40.3.415. [DOI] [PubMed] [Google Scholar]
  22. Ruddy S., Gigli I., Austen K. F. The complement system of man. I. N Engl J Med. 1972 Sep 7;287(10):489–495. doi: 10.1056/NEJM197209072871005. [DOI] [PubMed] [Google Scholar]
  23. Studd J. W., Blainey J. D., Bailey D. E. Serum protein changes in the pre-eclampsia-eclampsia syndrome. J Obstet Gynaecol Br Commonw. 1970 Sep;77(9):796–801. doi: 10.1111/j.1471-0528.1970.tb04401.x. [DOI] [PubMed] [Google Scholar]
  24. Thompson R. A., Lachmann P. J. Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7. J Exp Med. 1970 Apr 1;131(4):629–641. doi: 10.1084/jem.131.4.629. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Experimental Pathology are provided here courtesy of Wiley

RESOURCES